Authors: Valerian L. Altersberger, Lotte J. Stolze, Mirjam R. Heldner, Hilde Henon, Nicolas Martinez-Majander, Christian Hametner, Annika Nordanstig, Andrea Zini, Stefania Nannoni, Bruno Gonçalves, Christian H. Nolte, Philipp Baumgartner, Andreas Kastrup, Panagiotis Papanagiotou, Georg Kägi, Ronen R. Leker, Marialuisa Zedde, Alessandro Padovani, Alessandro Pezzini, Visnja Padjen, Carlo W. Cereda, Georges Ntaios, Leo H. Bonati, Leon A. Rinkel, Urs Fischer, Jan F. Scheitz, Susanne Wegener, Guillaume Turc, Patrik Michel, Mauro Gentile, Alexandros Rentzos, Peter A. Ringleb, Sami Curtze, Charlotte Cordonnier, Marcel Arnold, Paul J. Nederkoorn, Stefan T. Engelter, Henrik Gensicke

Venue: Stroke

Type: Article

Abstract: Timely reperfusion is an important goal in treatment of eligible patients with acute ischemic stroke. However, during the coronavirus disease 2019 (COVID-19) pandemic, prehospital and in-hospital emergency procedures faced unprecedented challenges, which might have caused a decline in the number of acute reperfusion therapy applied and led to a worsening of key quality measures for this treatment during lockdown. This prospective multicenter cohort study used data from the TRISP (Thrombolysis in Ischemic Stroke Patients) registry of patients wi... (read more)

DOI: 10.1161/strokeaha.120.032176